QL
NTLA icon

Quarry LP’s Intellia Therapeutics NTLA Stock Holding History

Quarry LP’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$541 Buy
+32
New +$448 ﹤0.01% 2147
2025
Q3 		– Sell
-237
Closed -$2.22K – 2398
2025
Q2 		$2.22K Buy
+237
New +$1.95K ﹤0.01% 1576
2024
Q2 		– Sell
-1,800
Closed -$49.5K – 2014
2024
Q1 		$49.5K Buy
+1,800
New +$50K 0.01% 466
2023
Q4 		– Sell
-1,500
Closed -$47.4K – 1547
2023
Q3 		$47.4K Buy
+1,500
New +$58.2K 0.01% 341

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Quarry LP's NTLA Position: Q2 2026 in Review

Quarry LP opened a new position in Intellia Therapeutics (NTLA) in Q2 2026: 32 shares worth $541. The stake represents ﹤0.01% of the portfolio and ranks #2147 among its holdings. This is a return to the name: Quarry LP previously reported a position in NTLA as recently as Q2 2025.

Quarry LP first reported a position in NTLA in Q3 2023 and has held it in 4 quarters since. The position peaked at $49.5K in Q1 2024. 329 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • Quarry LP held 32 shares of Intellia Therapeutics worth $541 as of Q2 2026.
  • Intellia Therapeutics was a new Quarry LP position in Q2 2026.
  • Intellia Therapeutics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #2147 holding.
  • Quarry LP first reported a position in Intellia Therapeutics in Q3 2023 and has held it in 4 quarters since.
  • Quarry LP's Intellia Therapeutics position peaked at $49.5K in Q1 2024.
  • 329 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.